|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.08 CAD | -0.92% |
|
-1.82% | +21.35% |
| 06-06 | Imaflex Higher as USPTO Grants Patent For ADVASEA | MT |
| 05-29 | Imaflex Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Imaflex Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was CAD 27.4 million compared to CAD 23.24 million a year ago. Net income was CAD 1.85 million compared to CAD 0.923 million a year ago.
Basic earnings per share from continuing operations was CAD 0.04 compared to CAD 0.02 a year ago. Diluted earnings per share from continuing operations was CAD 0.04 compared to CAD 0.02 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +21.35% | 41.2M | |
| +2.07% | 14.27B | |
| +16.25% | 9.6B | |
| -10.15% | 6.92B | |
| +34.00% | 1.47B | |
| +11.02% | 1.4B | |
| -18.36% | 1.22B | |
| +14.68% | 1.09B | |
| -30.19% | 927M | |
| +88.74% | 901M |
IMAFLEX INC. 
